Search Technologies

Showing 1-3 of 3 results found

Novel Fusion Proteins for HIV Vaccine

The National Cancer Institute’s Cancer and Inflammation Program seeks parties to license gp120 and CD4-induced antibody fusion proteins for use in an HIV vaccine.

Research Tools

CODEFACS and LIRICS: Computation Tools for Identifying Cell-Type Specific Gene Expression Levels in Tumors and Other Types of Samples

The National Cancer Institute (NCI) seeks co-development partners or licensees for CODEFACS, a transcriptomics deconvolution tool for analyzing cell-type specific gene expression in complex tissues, and LIRICS, a supporting framework for analyzing immune interactions in the tumor microenvironment.

Research Tools

Exo-Clean Technology for Purifying Extracellular Vesicle Preparations from Contaminants

Researchers at the National Cancer Institute (NCI) developed a novel biophysical technique to purify extracellular vesicles (EVs) from contaminants such as proteins and unbound labels. The NCI seeks licensees and/or co-development research collaborations to further advance this technology for EV-based biomarkers and therapeutics to treat a wide range of diseases.

Research Tools

You are here

Product Type

Development Stage

Therapeutic Area

Institutes and Centers

Search Technologies

Novel Fusion Proteins for HIV Vaccine

CODEFACS and LIRICS: Computation Tools for Identifying Cell-Type Specific Gene Expression Levels in Tumors and Other Types of Samples

Exo-Clean Technology for Purifying Extracellular Vesicle Preparations from Contaminants